{"product_id":"schrodinger-pestle-analysis","title":"Schrödinger PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic cycles, and rapid scientific innovation are shaping Schrödinger’s strategic outlook in our concise PESTLE snapshot—designed to spark timely decisions. This brief highlights key external drivers and risks; the full PESTLE delivers the deep data and actionable recommendations investors and strategists need. Purchase the complete report to access the full analysis and ready-to-use insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D public funding priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernment allocations to NIH (about $49B in FY2024), NSF (around $11B) and DoD RDT\u0026amp;E (~$120B) drive demand for computational discovery tools. Shifts toward pandemic readiness, oncology or advanced materials can expand grants and software spend for Schrödinger’s customers. Austerity or political turnover can slow grant cycles and purchases, so monitoring multi-year appropriations and programmatic focus is critical.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade policy and export controls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRestrictions on advanced software exports, encryption, and AI tech limit market access; since 2023 controls target items from firms representing over 80% of advanced chip manufacturing capacity. Tariffs and cross-border licensing add roughly a 3.5% average tariff-equivalent cost and increase deployment complexity. Geopolitical tensions can delay deals with state-affiliated labs; proactive compliance and diversified market exposure reduce risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial policy and tech sovereignty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eUS, EU and Asian policies push local innovation and digital sovereignty, shaping procurement toward domestic suppliers; the US CHIPS Act provides $52B, the EU targets ~€43B for chips and Horizon Europe has a €95.5B R\u0026amp;D budget. Subsidies for semiconductors, green tech and life sciences boost customer spending and deal flow. China and other markets enforce localization—China's 2017 cybersecurity law mandates local storage for critical data—aligning with national agendas can unlock funding and pilots.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare and drug pricing politics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cphealthcare and drug pricing politics squeeze margins: cbo estimates the inflation reduction act reduces medicare spending by about billion over years driving firms to reallocate from breadth high-value assets within a global pharma r pool near intensified pressure pushes investment into ai platform tools raise hit rates while regulatory uncertainty delays new project starts cost-saving infrastructure demand remains countercyclical.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eR\u0026amp;D pool ~ $200B (2023)\u003c\/li\u003e\n\u003cli\u003eIRA impact ~ $98B\/10y (CBO)\u003c\/li\u003e\n\u003cli\u003eHigher pricing pressure → AI\/platforms for productivity\u003c\/li\u003e\n\u003cli\u003eRegulatory uncertainty delays starts; cost-saving tools sustain demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/phealthcare\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment procurement and standards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePublic-sector labs mandate security, accessibility and procurement compliance, with procurement cycles commonly spanning 6–18 months and awarded contracts often providing 3–5 year revenue durability; winning one public contract can materially reduce churn. Preference for open standards and reproducibility favors interoperable platforms and data portability, boosting adoption; certifications such as ISO 27001, ISO 9001, CLIA or GxP increase credibility and access to funded programs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e6–18 month procurement cycles\u003c\/li\u003e\n\u003cli\u003e3–5 year contract durability\u003c\/li\u003e\n\u003cli\u003eOpen standards → interoperability, reproducibility\u003c\/li\u003e\n\u003cli\u003eISO 27001 \/ ISO 9001 \/ CLIA \/ GxP = market access\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovt R\u0026amp;D \u0026amp; incentives fuel computational discovery - NIH \u003cstrong\u003e$49B\u003c\/strong\u003e, DoD \u003cstrong\u003e$120B\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment allocations (NIH $49B FY2024, NSF $11B, DoD RDT\u0026amp;E ~$120B) and CHIPS $52B, EU €43B, Horizon €95.5B boost demand for computational discovery. Export controls since 2023 cover ~80% advanced chip capacity; tariffs add ~3.5% cost and localization rules (China) shift procurement. IRA ~$98B\/10y and global pharma R\u0026amp;D ~$200B (2023) push AI\/platform spending; public contracts 6–18m cycles, 3–5y duration.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNIH (FY2024)\u003c\/td\u003e\n\u003ctd\u003e$49B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNSF\u003c\/td\u003e\n\u003ctd\u003e$11B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDoD RDT\u0026amp;E\u003c\/td\u003e\n\u003ctd\u003e$120B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCHIPS\u003c\/td\u003e\n\u003ctd\u003e$52B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHorizon Europe\u003c\/td\u003e\n\u003ctd\u003e€95.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIRA impact\u003c\/td\u003e\n\u003ctd\u003e$98B\/10y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Schrödinger across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—combining data-driven trends, region- and industry-specific examples, forward-looking insights, and clean formatting to support executives and investors in identifying risks and opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe Schrödinger PESTLE Analysis condenses complex external factors into a visually segmented, editable summary that’s ready to drop into presentations or share across teams. It simplifies stakeholder alignment, supports risk discussions, and lets users add context-specific notes for quick, actionable planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharma R\u0026amp;D spending cycle\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWith the US federal funds rate holding at 5.25–5.50% since 2023, higher borrowing costs compressed biotech cash runways and software budgets; global life‑sciences VC funding fell ~40% to about $27B in 2024 (PitchBook). Big Pharma kept aggregate R\u0026amp;D near pre‑downturn levels (roughly $200B+ globally) but reprioritized pipelines under macro pressure. Schrödinger benefits as customers seek computational efficiency, and multi‑year licenses\/services boost revenue visibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVenture and capital market dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVenture and capital market dynamics shape Schrödinger's early-stage market: life‑science VC fell roughly 40% from 2021 peaks and began rebounding in 2024, affecting IPOs, follow‑ons and venture flows that constrain startup tool purchases during droughts and free backlog on recovery; flexible pricing and startup programs preserve pipeline, while partnering and co‑development shift commercialization risk and speed adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnterprise software procurement trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eShift to SaaS and opex models now account for roughly 70% of enterprise software procurement, with bundling reshaping deal structures and payment terms. CFO scrutiny favors ROI-proofed platforms—about 68% of CFOs in 2024 require measurable ROI and cycle-time reductions. Land-and-expand motions enable net revenue retention of 110–130% for top sellers, while multi-tenant efficiency can lift gross margins by 5–15 points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eForeign exchange and global revenue mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eUSD strength\/weakness materially shifts reported revenues and pricing competitiveness for Schrödinger given significant USD-denominated contracts; company disclosures note active hedging and local-currency pricing to smooth volatility and protect margins. Regional growth in APAC and EU provides diversification of demand and FX exposure, while billing-currency alignment reduces conversion friction and commercial risk.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFX impact: hedging reduces reported volatility\u003c\/li\u003e\n\u003cli\u003eLocal pricing: protects margins\u003c\/li\u003e\n\u003cli\u003eAPAC\/EU growth: diversifies exposure\u003c\/li\u003e\n\u003cli\u003eBilling currency alignment: lowers conversion friction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInput costs and talent markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHighly skilled computational chemistry and ML talent remains expensive, with senior roles often commanding total compensation above $180,000 in the US (Levels.fyi 2024–2025); wage inflation plus rising cloud compute costs (Gartner 2024: cloud infrastructure spending ~20% YoY growth) are squeezing gross margins. Nearshoring and workload optimization can cut unit costs materially, while strategic partnerships help absorb 20–30% of peak demand.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTalent: \u0026gt;$180k+ total comp (Levels.fyi 2024–2025)\u003c\/li\u003e\n\u003cli\u003eCloud: ~20% YoY infra spend growth (Gartner 2024)\u003c\/li\u003e\n\u003cli\u003eNearshoring: unit cost cuts 10–25%\u003c\/li\u003e\n\u003cli\u003ePartnerships: offset ~20–30% peak demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovt R\u0026amp;D \u0026amp; incentives fuel computational discovery - NIH \u003cstrong\u003e$49B\u003c\/strong\u003e, DoD \u003cstrong\u003e$120B\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWith US funds rate 5.25–5.50% since 2023, borrowing tightened biotech budgets and VC fell ~40% to $27B in 2024. Big Pharma kept R\u0026amp;D ~200B+ but reprioritized pipelines, favoring computational efficiency and multi‑year deals. Cloud spend +20% YoY and senior comp \u0026gt;$180k squeeze margins; APAC\/EU growth and hedging diversify FX risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eYear\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVC funding\u003c\/td\u003e\n\u003ctd\u003e$27B\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed rate\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003ctd\u003e2023–25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud spend growth\u003c\/td\u003e\n\u003ctd\u003e~20% YoY\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior comp\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$180k\u003c\/td\u003e\n\u003ctd\u003e2024–25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eSchrödinger PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Schrödinger PESTLE Analysis document you’ll receive after purchase—fully formatted and ready to use. This screenshot reflects the real product delivered exactly as shown, with no placeholders or teasers. Download the final, professionally structured file immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55675919827321,"sku":"schrodinger-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/schrodinger-pestle-analysis.png?v=1755810155","url":"https:\/\/portersfiveforce.com\/products\/schrodinger-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}